State of CVC Q3’24 Report
CVCs show heightened interest in early-stage rounds, even as CVC dealmaking falls to its lowest level since 2018.
CVCs show heightened interest in early-stage rounds, even as CVC dealmaking falls to its lowest level since 2018.
Quarterly AI deal count spikes to reach highest level since Q1’22 peak.
Dive into the latest AI activity, and discover the emerging trends our data is signaling.
While global funding falls, M&A activity picks up in digital health.
Fintech deal volume reaches its lowest point since 2017 as investors shift bets to more emerging areas of opportunity.
In this webinar, our expert dives into venture activity, highlighting the emerging trends our data is signaling.
AI startups grab 1 in 3 VC dollars. Silicon Valley is becoming even more dominant. Positive signs from tech IPOs. We break down key changes in the venture landscape.
Climate tech experiences a unicorn drought as funding continues to drop.
Insurtech funding sees its strongest quarter in over a year despite deal volume sinking to its lowest point since 2016.
$100M+ mega-rounds drive growth in corporate venture capital-backed funding in Q2’24, while deal activity falters.
AI funding hits $23.2B in Q2’24 — the highest quarterly level on record.
Funding in digital health drops, but larger check sizes and an uptick in exits highlight bright spots for the industry in Q2’24.
Two blockbuster deals buoy an otherwise flat quarter for the sector.
Midway through 2024, AI startups continue to steal the show. Now, our expert is diving into the trends shaping the space.
AI startups steal the show, grabbing over a third of all funding, while the rest of the venture ecosystem remains tepid in Q2’24.
In this webinar, our expert digs into where funding is going, trends in deal activity, and which sectors are seeing the most (and least) momentum.
Corporate venture capital funding rebounds in Q1'24, driven by $100M+ mega-rounds.
Global insurtech funding falls to its lowest quarterly level since 2018.
AI funding hits a 4-quarter high — fueled by massive genAI rounds — while deals continue to fall in Q1’24.
While digital health funding rebounds in Q1'24, deal count hits a multi-year low.
Investors remain cautious in fintech, with funding declining to its lowest quarterly level since 2017 even as deals tick up.
After a tumultuous 2023, digital health funding surged in Q1’2024. What caused the rebound? And will the upward trend continue? Find out directly from the experts.
VC dealmaking slides to a 7-year low, while several blockbuster deals drive a modest rebound in funding.
What's the state of venture? And what’s the data signaling will happen next?
Corporate venture capital-backed deals and dollars fall to multi-year lows as CVCs shield themselves from the volatile tech market.
Our expert dives into the generative AI landscape across funding trends, top-valued startups, most active VCs, and more.